FdaApplication
NDA 212125
Identifiers
- fda_app_no: NDA212125
Properties
| Property | Value |
|---|---|
| applicant_name | TEVA PHARMACEUTICALS USA INC |
| application_type | NDA |
| approval_date | 2021-07-30 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| MICAFUNGIN | MICAFUNGIN SODIUM | EQ 100MG BASE/VIAL | POWDER;INTRAVENOUS |
| MICAFUNGIN | MICAFUNGIN SODIUM | EQ 50MG BASE/VIAL | POWDER;INTRAVENOUS |
2 products